These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 17516082
1. False negative 17-hydroxyprogesterone screening in children with classical congenital adrenal hyperplasia. Schreiner F, Brack C, Salzgeber K, Vorhoff W, Woelfle J, Gohlke B. Eur J Pediatr; 2008 Apr; 167(4):479-81. PubMed ID: 17516082 [Abstract] [Full Text] [Related]
2. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening. Castro PS, Rassi TO, Araujo RF, Pezzuti IL, Rodrigues AS, Bachega TASS, Silva IN. J Pediatr Endocrinol Metab; 2019 May 27; 32(5):499-504. PubMed ID: 31028712 [Abstract] [Full Text] [Related]
3. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants. Kopacek C, de Castro SM, Prado MJ, da Silva CM, Beltrão LA, Spritzer PM. BMC Pediatr; 2017 Jan 17; 17(1):22. PubMed ID: 28095810 [Abstract] [Full Text] [Related]
7. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening. Liu SY, Lee CT, Tung YC, Chien YH, Hwu WL, Tsai WY. J Formos Med Assoc; 2018 Feb 17; 117(2):126-131. PubMed ID: 28392195 [Abstract] [Full Text] [Related]
8. Molecular analysis of CYP21A2 can optimize the follow-up of positive results in newborn screening for congenital adrenal hyperplasia. Silveira EL, Elnecave RH, dos Santos EP, Moura V, Pinto EM, van der Linden Nader I, Mendonca BB, Bachega TA. Clin Genet; 2009 Dec 17; 76(6):503-10. PubMed ID: 19930153 [Abstract] [Full Text] [Related]
9. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls. Varness TS, Allen DB, Hoffman GL. J Pediatr; 2005 Oct 17; 147(4):493-8. PubMed ID: 16227036 [Abstract] [Full Text] [Related]
10. Neonatal screening for congenital adrenal hyperplasia in Taiwan: a pilot study. Chu SY, Tsai WY, Chen LH, Wei ML, Chien YH, Hwu WL. J Formos Med Assoc; 2002 Oct 17; 101(10):691-4. PubMed ID: 12517042 [Abstract] [Full Text] [Related]
11. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995. Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza D, Pirazzoli P, Zappulla F. Pediatrics; 1996 Sep 17; 98(3 Pt 1):362-7. PubMed ID: 8784357 [Abstract] [Full Text] [Related]
13. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening. Sarafoglou K, Lorentz CP, Otten N, Oetting WS, Grebe SK. Clin Genet; 2012 Jul 17; 82(1):64-70. PubMed ID: 21534945 [Abstract] [Full Text] [Related]